Phase I Study of Bendamustine and Fractionated Stereotactic Radiotherapy of Patients With 1- 4 Brain Metastases From Solid Malignancies
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Bendamustine (Primary)
- Indications Brain metastases; Solid tumours
- Focus Adverse reactions
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 14 May 2018 Status changed from active, no longer recruiting to completed.
- 22 Feb 2017 Planned End Date changed from 1 Dec 2016 to 31 Dec 2017.